In yesterday’s Wall Street session, 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) shares traded at $1.06, up 37.52% from the previous session.
SXTP stock price is now -7.94% away from the 50-day moving average and -43.81% away from the 200-day moving average. The market capitalization of the company currently stands at $2.43M.
In other news, XU CHERYL, Director bought 6,000 shares of the company’s stock on Dec 13 ’24. The stock was bought for $9,375 at an average price of $1.56. Upon completion of the transaction, the Director now directly owns 52,078 shares in the company, valued at $55202.68. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 12 ’24, Director XU CHERYL bought 5,000 shares of the business’s stock. A total of $9,125 was incurred on buying the stock at an average price of $1.82. This leaves the insider owning 46,078 shares of the company worth $48842.68. A total of 20.10% of the company’s stock is owned by insiders.
During the past 12 months, 60 Degrees Pharmaceuticals Inc has had a low of $0.70 and a high of $7.20. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 5.26, and a quick ratio of 4.91. The fifty day moving average price for SXTP is $1.14976 and a two-hundred day moving average price translates $1.897655 for the stock.
The latest earnings results from 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was released for 2024-06-30. The net profit margin was -1773.90% and return on equity was -124.71% for SXTP. The company reported revenue of $0.15 million for the quarter, compared to $0.13 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 16.54 percent. For the current quarter, analysts expect SXTP to generate $234k in revenue.
